SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-036485
Filing Date
2018-05-29
Accepted
2018-05-29 19:19:09
Documents
1
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 12576
  Complete submission text file 0001104659-18-036485.txt   13967
Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
BOESS CARSTEN (Reporting) CIK: 0001277495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 18866137

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences